In addition, the survival analysis of 64 RCC patients in TCGA‐KICH database suggested a worse prognosis in patients with high expression of CSNK1G3, including both linear mRNA and circular RNA expression, compared with patients with low expression of CSNK1G3 (Figure 1C). This evidence concerns the gene CSNK1G3 and renal cell carcinoma.